期刊文献+

口腔鳞状细胞癌患者血清中IL-27的表达及临床意义 被引量:2

Expression and clinical significance of serum interleukin-27 level in patients with oral squamous cell carcinoma
下载PDF
导出
摘要 目的:检测白细胞介素27(IL-27)在口腔鳞状细胞癌(oral squamous cell carcinoma,OSCC)患者血清中的表达,探讨其与OSCC临床病理因素的相关性。方法:应用酶联免疫反应(enzyme-linked immunosorbent assay,ELISA)检测40例OSCC患者和20例健康体检者血清中的IL-27水平。采用SPSS10.0软件包对检测数据进行t检验。结果 :OSCC患者血清中IL-27水平显著高于对照组(P<0.05),临床Ⅲ、Ⅳ期OSCC患者血清中IL-27水平显著高于Ⅰ、Ⅱ期患者(P<0.05);有颈淋巴结转移患者,血清IL-27水平显著高于无转移者(P<0.05)。结论:血清IL-27水平与口腔鳞状细胞癌的病理分级、临床分期及颈淋巴结转移密切相关。 PURPOSE: To explore the clinical significance of serum interleukin-27 (IL-27) level in patients with oral squamous ceil carcinoma (OSCC). METHODS: Forty patients pathologically confirmed as OSCC were included, and 20 healthy adults were used as controls. The serum IL-27 were tested with enzyme -linked immunosorbent assay(ELISA). Statistical analysis was performed by SPSS10.0 software package and t test was used to determine the difference. RESULTS: The level of serum IL-27 in OSCC patients was significantly higher than that in the control group (P〈0.05). The high expression of IL-27 correlated with clinical pathologic stage (P〈0.05) and cervical lymph node metastasis (P〈 0.05). CONCLUSION: The expression of serum IL-27 correlates significantly with the clinicopathologic stages of OSCC. Supported by National Natural Science Foundation of China (81001205).
作者 刘琪 孙祖俊
出处 《上海口腔医学》 CAS CSCD 北大核心 2013年第2期181-183,共3页 Shanghai Journal of Stomatology
基金 国家自然科学基金(81001205)~~
关键词 IL-27 口腔鳞状细胞癌 酶联免疫反应 IL-27 Oral squamous cell carcinoma ELISA
  • 相关文献

参考文献12

  • 1Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells[J]. Immunity, 2002, 16(6): 779-790.
  • 2Villarino AV, Huang E, Hunter CA. Understanding the pro- and anti-inflammatory properties of IL-27[J]. J Immunol,2004,173(2): 715-720.
  • 3Owaki T, Asakawa M, Morishima N, et al. A role for IL-27 in early regulation of Thl differentiation[J]. J Immunol,2005,175(4): 2191-2200.
  • 4Murugaiyan G, Mittal A, Lopez-Diego R, et al. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+T cells[J]. J Immunol, 2009, 183(4): 2435-2443.
  • 5Villafino AV, Hunter CA. Biology of recently discovered cytokines: discerning the pro- and anti-inflammatory properties of interleukin-27[J]. Arthritis Res Ther, 2004, 6(5): 225-233.
  • 6Guzzo C, Ayer A, Basta S, et al. IL-27 enhances LPS-induced proinflammatory cytokine production via upregulation of TLR4 expression and signaling in human monocytes [J]. J Immunol, 2012, 188(2): 864-873.
  • 7Shimizu M, Shimamura M, Owaki T, et al. Antiangiogenic and antitumor activities of IL-27 [J]. J Immunol, 2006, 176 (12): 7317-7324.
  • 8Hisada M, Kamiya S, Fujita K, et al. Potent antitumor activity of interleukin-27[J]. Cancer Res, 2004, 64(3): 1152-1156.
  • 9Chiyo M, Shimozato O, Yu L, et al. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals [J]. Int J Cancer, 2005, 115(3): 437-442.
  • 10Zolochevska O, Xia X, Williams BJ, et al. Sonoporation delivery of Interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo[J]. Hum Gene Ther, 2011, 22(12): 1537-1550.

同被引文献44

  • 1Bosmann M,Ward PA. Modulation of inflammation by interleukin-27[J].{H}Journal of Leukocyte Biology,2013.1159-1165.
  • 2Devergne O,Hummel M,Koeppen H. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes[J].{H}Journal of Virology,1996.1143-1153.
  • 3Pflanz S,Timans JC,Cheung J. IL-27,a heterodimeric cytokine composed of EBI3 and p28 protein,induces proliferation of naive CD4(+)T cells[J].{H}IMMUNITY,2002.779-790.
  • 4Liu J,Guan X,Ma X. Regulation of IL-27 p28 gene expression in macrophages through MyD88-and interferon-gamma-mediated pathways[J].J Exp,2007.141-152.
  • 5Sonobe Y,Yawata I,Kawanokuchi J. Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations[J].{H}Brain Research,2005.202-207.
  • 6Wirtz S,Becker C,Fantini MC. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation[J].{H}Journal of Immunology,2005.2814-2824.
  • 7Pflanz S,Hhibbert L,Mattson J. WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27[J].{H}Journal of Immunology,2004.2225-2231.
  • 8Sprecher CA,Grant FJ,Baumgartner JW. Cloning and characterization of a novel classⅠ cytokine receptor[J].{H}Biochemical and Biophysical Research Communications,1998.82-90.
  • 9Chen Q,Ghilardi N,Wang H. Development of Th1-type immune responses requires the typeⅠ cytokine receptor TCCR[J].{H}NATURE,2000.916-920.
  • 10Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily[J].{H}Proceedings of the National Academy of Sciences(USA),1990.6934-6938.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部